Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 30, 2006Annals of Pharmacotherapy

Pharmacokinetics of Oseltamivir in Young and Very Elderly Subjects

View Full Paper
Ask AI
Bookmark
Share

Authors

MAMasaichi AbeChugai Pharma (United States)JSJames SmithIndiana University School of MedicineAUAkinori UraeMidas Mediscience (United Kingdom)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Abe et al. (2006) studied this question.

synapsesocial.com/papers/6a87f4e46304c7fd8e4de800https://doi.org/10.1345/aph.1h174
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Oral oseltamivir treatment of influenza in children2001 · 718 citations
  2. 2The Pharmacokinetics and Tolerability of the Oral Neuraminidase Inhibitor Oseltamivir (Ro 64–0796/GS4104) in Healthy Adult and Elderly Volunteers2000 · 85 citations
  3. 3Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection1998 · 255 citations